HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Myers, C. L. Articles by Shlafer, M. Search for Related Content PubMed PubMed Citation Articles by Myers, C. L. Articles by Shlafer, M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 91, 281-289, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts

CL Myers, SJ Weiss, MM Kirsh, BM Shepard and M Shlafer

We evaluated whether supplemental pharmacologic interventions that altered formation or degradation of reactive oxygen metabolites, when added to hypothermic crystalloid cardioplegic solution (procaine-free St. Thomas' Hospital solution), alter postischemic function of isolated rabbit hearts. Hypoxic, substrate-free cardioplegic solutions cooled to 27 degrees C were perfused through isolated rabbit hearts for 5 minutes before and after an uninterrupted 2 hour period of global ischemia at 27 degrees C. Hearts were then reperfused with standard buffer for 1 hour at 37 degrees C. In some experiments, the cardioplegic solution was supplemented with the following: superoxide dismutase (30 micrograms/ml; degrades superoxide anion); catalase (1.7 micrograms/ml; degrades hydrogen peroxide); allopurinol (1 mmol/L; inhibits xanthine oxidase); or deferoxamine (Desferal, 0.5 mmol/L; selectively chelates ferric iron). Postreperfusion contractile parameters of supplemented hearts, including left ventricular pressure development and its first derivative, left ventricular compliance, spontaneous heart rate, and coronary vascular resistance, were statistically compared to data obtained from hearts arrested with unsupplemented cardioplegic solution. Catalase supplementation provided statistically significant improvement of most functional parameters; somewhat less protection was obtained with allopurinol. Deferoxamine provided little added protection except for the ability to prevent ischemia-induced increases of coronary vascular resistance. There was no evidence of added protection by superoxide dismutase. The data suggest that an important component of ischemia-induced cardiac cell damage in an asanguineous setting is hydrogen peroxide-dependent, and interventions that either inhibit production of superoxide anion or degrade hydrogen peroxide offer best protection. They may be clinically efficacious additives to crystalloid cardioplegic solutions.

This article has been cited by other articles:

				P. Pacher, A. Nivorozhkin, and C. Szabo Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114. [Abstract] [Full Text] [PDF]

				R. Bolli and E. Marban Molecular and Cellular Mechanisms of Myocardial Stunning Physiol Rev, April 1, 1999; 79(2): 609 - 634. [Abstract] [Full Text] [PDF]

				M. L. Myers, P. Farhangkhoee, and M. Karmazyn Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) Cardiovasc Res, November 1, 1998; 40(2): 290 - 296. [Abstract] [Full Text] [PDF]

				S. R. Powell, L. Aiuto, D. Hall, and A. J. Tortolani ZINC SUPPLEMENTATION ENHANCES THE EFFECTIVENESS OF ST. THOMAS' HOSPITAL NO. 2 CARDIOPLEGIC SOLUTION IN AN IN VITRO MODEL OF HYPOTHERMIC CARDIAC ARREST J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1642 - 1648. [Abstract] [Full Text]

				T. Sisto, H. Paajanen, T. Metsa-Ketela, A. Harmoinen, I. Nordback, and M. Tarkka Pretreatment With Antioxidants and Allopurinol Diminishes Cardiac Onset Events in Coronary Artery Bypass Grafting Ann. Thorac. Surg., June 1, 1995; 59(6): 1519 - 1523. [Abstract] [Full Text]

				R. S. Finley Overview of Biotechnology in Health Care Journal of Pharmacy Practice, January 1, 1991; 4(2): 80 - 86. [PDF]

				W.P. Chan, B. Bharadwaj, and K. Prasad Effects of Diltiazem on the Functional Recovery of the Myocardium at Organ and Cellular Level During Prolonged Hypothermic Ischemic Cardiac Arrest Angiology, September 1, 1990; 41(9): 702 - 714. [Abstract] [PDF]

				Hou Di, W.-y. Liu, F.-z. Fang, Mo Jian, S.-f. Sun, W.-r. Shi, J.-m. Ye, Y.-f. Guan, and Liu Jian The experimental study of prevention of myocardial reperfusion injury with free radical scavengers Perfusion, July 1, 1988; 3(3): 205 - 212. [Abstract] [PDF]